The effect of nitric oxide on the production of cyclic AMP by a human osteoblast (HOS) cell line stimulated with hydroxyapatite

Biomedicine and Pharmacotherapy

Volumn 62, Issue 5, 2008, Pages 328-332

  Sosroseno, Wihaskoro ^a,b   Sugiatno, Erwan ^b,c   Samsudin, Abdul R ^b   Ibrahim, M Fikri ^b  

^a AIMST UNIVERSITY   (Malaysia)

^b SCHOOL OF PHYSICS   (Malaysia)

^c GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

cAMP; Hydroxyapatite; Nitric oxide; Osteoblast

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE INHIBITOR; CD51 ANTIGEN; CYCLIC AMP; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYAPATITE; N5 (1 IMINOETHYL)ORNITHINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROSO ACETYLPENICILLAMINE; PENICILLAMINE DERIVATIVE; S NITROSO ACETYLPENICILLAMINE; SCAVENGER;

ARTICLE; CELL CULTURE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BINDING; SUPERNATANT; UPREGULATION;

ADENINE; ADENYLATE CYCLASE; ANTIBODIES; CELL LINE; CYCLIC AMP; CYCLIC GMP; CYCLIC N-OXIDES; DURAPATITE; FREE RADICAL SCAVENGERS; HUMANS; IMIDAZOLES; INTEGRIN ALPHAV; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE III; ORNITHINE; OSTEOBLASTS; S-NITROSO-N-ACETYLPENICILLAMINE; STIMULATION, CHEMICAL;

EID: 44449122303     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.10.003     Document Type: Article

References (23)

1. Chin K.-V., Yang W.-L., Ravatn R., Kita T., Reitman E., Vettori D., et al. Reinventing the wheel of cyclic AMP: novel mechanisms of cAMP signaling. Ann N Y Acad Sci 968 (2002) 49
2. Swarthout J.T., D'Alonzo R.C., Selvamurugan N., and Partridge N.C. Parathyroid hormone-dependent signaling pathway regulating genes in bone cells. Gene 282 (2002) 1
3. 2 induces the gene expression of bone matrix metalloprotein-1 in mouse osteoblastic by cAMP-PKA signaling pathway. Int J Biochem Cell Biol 37 (2005) 375
4. Ushida T., Uemura T., and Tateishi T. Changes in cell proliferation, alkaline phosphatase activity and AMP production by mechanical strain in osteoblast-like cells differentiated from rat bone marrow. Mater Sci Eng 17 (2001) 51
5. Faucheux N., Correze C., Haye B., and Nagel M.D. Accumulation of cyclic AMP in Swiss 3T3 cells adhering to a cellulose biomaterial substratum through interaction with adenylyl cylase. Biomaterials 22 (2001) 2993
6. Faucheux N., and Nagel M.D. Cyclic AMP-dependent aggregation of Swiss 3T3 on a cellulose substratum (uprophan) and decreased ell membrane Rho A. Biomaterials 23 (2002) 2295
7. Van't Hof R.J., and Ralston S.H. Nitric oxide and bone. Immunology 103 (2001) 255
8. Mungrue I.N., Bredt D.S., Stewart D.J., and Husain M. From molecules to mammals: what's NOS got to do with it?. Acta Physiol Scand 179 (2003) 123
9. Sosroseno W, Sugiatno E, Samsudin AR, Ibrahim MF. The role of nitric oxide on the proliferation of a human osteoblast (HOS) cell line stimulated with hydroxyapatite, submitted for publication.
10. 2 production by a human osteoblast cell line (HOS) stimulated with hydroxyapatite. Biomed Pharmacother 60 (2006) 147
11. Michell B.J., Chen Z.-P., Tiganis T., Stapleton D., Katsis F., Power D.A., et al. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276 (2001) 17625
12. 2 and selective prostaglandin receptor agonists in murine osteoblastic cells. Bone 34 (2004) 827
13. Faucheux N., Warocquier-Clérout R., Duval J.L., Haye B., and Nagel M.D. cAMP levels in cells attached to AN69 and cuprophan: cAMP dependence of cell aggregation and the influence of serum. Biomaterials 20 (1999) 159
14. 3 in cultured human osteoblastic cells. Exp Cell Res 244 (1998) 71
15. Otsuka E., Hirano K., Matsushita S., Inoue A., Hirose S., Yamaguchi A., et al. Effects of nitric oxide from exogenous nitric oxide donors on osteoblastic metabolism. Eur J Pharmacol 349 (1998) 345
16. Mancini L., Moradi-Bidhendi N., Becherini L., Martineti V., and MacIntyre I. The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent. Biochem Biophys Res Commun 274 (2000) 477
17. Miyakoshi M., Yamada T., Katayama H., Murayama T., and Nomura Y. Regulation of cyclic GMP and cyclic AMP production by S-nitroso-cysteine in rat thymocytes. Eur J Pharmacol 359 (1998) 235
18. Villa-Petroff M.G., Younes A., Egan J., Lakata E.G., and Sollot S.J. Activation of distinct cAMP-dependent and cGMP-dependent pathway by nitric oxide in cardiac myocytes. Circ Res 19 (1999) 1093
19. Hill J., Howlett A., and Klein C. Nitric oxide selectively inhibits adenylyl cyclase isoforms 5 and 6. Cell Signal 12 (2000) 233
20. Hata A.N., and Beyer R.M. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 103 (2004) 147
21. DeMali K.A., Wennerberg K., and Burridge K. Integrin signaling to the actin cytoskeleton. Curr Opin Cell Biol 15 (2003) 572
22. Ruegg C., Dormond O., and Marrioti A. Endothelial cell integrin and COX-2 mediator and therapeutic targets of tumor angiogenesis. Biochim Biophys Acta 1654 (2004) 51
23. LeGeros R.Z. Properties of osteoconductive biomaterials: calcium phosphate. Clin Orthopead Relat Res 395 (2002) 81